Evidence map›Paper›PMID 35344659›Full record

ArticleACS biomaterials science & engineering2022

Foscarnet-Type Inorganic-Organic Hybrid Nanoparticles for Effective Antiviral Therapy.

Mikhail Khorenko, Ulfert Rand, Luka Cicin-Sain, Claus Feldmann

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS biomaterials science & engineering, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Mikhail KhorenkoInstitute of Inorganic Chemistry, Karlsruhe Institute of Technology (KIT), Engesserstrasse 15, D-76131 Karlsruhe, Germany.
Ulfert RandHelmholtz Center for Infection Research, Inhoffenstraße 7, D-38124 Braunschweig, Germany.
Luka Cicin-SainHelmholtz Center for Infection Research, Inhoffenstraße 7, D-38124 Braunschweig, Germany.
Claus FeldmannInstitute of Inorganic Chemistry, Karlsruhe Institute of Technology (KIT), Engesserstrasse 15, D-76131 Karlsruhe, Germany.ORCID 0000-0003-2426-9461
Helmholtz Centre for Infection Research · DEKarlsruhe Institute of Technology · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[ZrO]

Indexed as

Herpesvirus 1, HumanNanoparticlesAntiviral AgentsCytomegalovirusFoscarnetHumansAntiviral AgentsFoscarnetantiviralcytomegalovirusfoscarnetinorganic-organic hybrid nanoparticlesnanocarrier

Identifiers

PMID35344659
PMCPMC9007112
OpenAlexW4220965775

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.